E-LIB Suche - Ergebnisse für: Werth, V.P.

1

Phase 2 BELIEVE study part B: Efficacy and safety of rilzab..:

Murrell, D.F. ; Patsatsi, A. ; Stavropoulos, P....
Journal of the European Academy of Dermatology and Venereology. 36 (2022) 10 - p. , 2022

Link: https://doi.org/10.1111/..

2

Immunological and clinical heterogeneity in cutaneous lupus..:

Vazquez, T. ; Feng, R. ; Williams, K. J..
British Journal of Dermatology. 185 (2021) 3 - p. 480-481 , 2021

Link: https://doi.org/10.1111/..

3

Establishing cut‐off values for mild, moderate and severe d..:

Krain, R.L. ; Bax, C.E. ; Chakka, S....
British Journal of Dermatology. 184 (2021) 5 - p. 975-977 , 2021

Link: https://doi.org/10.1111/..

4

Postinflammatory hyperpigmentation and erythema: new insigh..:

Concha, J.S.S. ; Afarideh, M. ; Werth, V.P.
British Journal of Dermatology. 186 (2021) 3 - p. 390-391 , 2021

Link: https://doi.org/10.1111/..

5

Proof of concept for the clinical effects of oral rilzabrut..:

Murrell, D.F. ; Patsatsi, A. ; Stavropoulos, P....
British Journal of Dermatology. 185 (2021) 4 - p. 745-755 , 2021

Link: https://doi.org/10.1111/..

6

PRO68 Patient-Reported Outcomes in Patients with Pemphigus ..:

Kapre, A. ; Werth, V.P. ; Pordeli, P..
Value in Health. 24 (2021) - p. S210 , 2021

Link: https://doi.org/10.1016/..

7

The incidence of bullous pemphigoid continues to increase i..:

Bax, C.E. ; Werth, V.P.
British Journal of Dermatology. 184 (2020) 1 - p. 5-6 , 2020

Link: https://doi.org/10.1111/..

8

Identifying the required degree of disease clearance to imp..:

Bax, C.E. ; Ravishankar, A. ; Yan, D....
British Journal of Dermatology. 184 (2020) 3 - p. 573-575 , 2020

Link: https://doi.org/10.1111/..

9

The validity and utility of the Cutaneous Disease Area and ..:

Ahmed, S. ; Chen, K.L. ; Werth, V.P.
Seminars in Arthritis and Rheumatism. 50 (2020) 3 - p. 458-462 , 2020

Link: https://doi.org/10.1016/..

10

Patient‐oriented outcomes for atopic dermatitis:

Vazquez, T. ; Concha, J.S.S. ; Werth, V.P.
British Journal of Dermatology. 184 (2020) 5 - p. 794-795 , 2020

Link: https://doi.org/10.1111/..

11

儿科皮肤病专家和风湿病专家对 CLASI 的评估:

Kushner, C.J. ; Tarazi, M. ; Gaffney, R.G....
British Journal of Dermatology. 180 (2019) 1 - p. e24-e24 , 2019

Link: https://doi.org/10.1111/..

12

Cross‐cultural adaptations of health‐related quality of lif..:

Chakka, S. ; Werth, V. P.
British Journal of Dermatology. 181 (2019) 4 - p. 659-660 , 2019

Link: https://doi.org/10.1111/..

13

A double‐blind, randomized, placebo‐controlled, phaseIItria..:

Werth, V.P. ; Merrill, J.T.
British Journal of Dermatology. 180 (2019) 5 - p. 964-965 , 2019

Link: https://doi.org/10.1111/..

14

Developing classification criteria for skin‐predominant der..:

Concha, J.S.S. ; Pena, S. ; Gaffney, R. G....
British Journal of Dermatology. 182 (2019) 2 - p. 410-417 , 2019

Link: https://doi.org/10.1111/..

15

Fatigue in autoimmune skin diseases:

Tarazi, M. ; Gaffney, R.G. ; Pearson, D...
British Journal of Dermatology. 180 (2019) 6 - p. , 2019

Link: https://doi.org/10.1111/..